For research use only. Not for therapeutic Use.
XX-650-23(Cat No.:I038465)is an investigational small molecule compound being developed for its potential in treating various cancers. It is designed to target and inhibit specific proteins involved in tumor cell growth, survival, and metastasis. By disrupting critical signaling pathways, XX-650-23 aims to reduce tumor proliferation and enhance the effectiveness of existing cancer therapies. Preclinical studies have shown encouraging results, demonstrating its ability to suppress tumor growth in several cancer models. Ongoing clinical trials are evaluating its safety, efficacy, and potential as a targeted therapy for various solid tumors and hematologic cancers.
CAS Number | 117739-40-9 |
Synonyms | N-(4-cyanophenyl)-3-hydroxynaphthalene-2-carboxamide |
Molecular Formula | C18H12N2O2 |
Purity | ≥95% |
IUPAC Name | N-(4-cyanophenyl)-3-hydroxynaphthalene-2-carboxamide |
InChI | InChI=1S/C18H12N2O2/c19-11-12-5-7-15(8-6-12)20-18(22)16-9-13-3-1-2-4-14(13)10-17(16)21/h1-10,21H,(H,20,22) |
InChIKey | DRBIYQSSEMTUJQ-UHFFFAOYSA-N |
SMILES | C1=CC=C2C=C(C(=CC2=C1)C(=O)NC3=CC=C(C=C3)C#N)O |